BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1279889)

  • 41. Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity.
    Lambertenghi-Deliliers G; Orazi A; Luksch R; Annaloro C; Soligo D
    Br J Haematol; 1991 Jun; 78(2):161-6. PubMed ID: 1712222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative morphometric study of immunohistochemical versus conventional staining for the evaluation of megakaryocytopoiesis in normal and pathological bone marrow biopsies.
    Marisavljević D; Radosević-Radojković N; Rolović Z
    Pathol Int; 1997 May; 47(5):301-7. PubMed ID: 9143025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between morphological classification of the degree of maturation and the ploidy of micromegakaryocytes in myelodysplastic syndrome patients.
    Kobayashi Y; Uoshima N; Kimura S; Tanaka K; Wada K; Ozawa M; Maruo N; Kondo M
    Int J Hematol; 1995 Apr; 61(3):117-22. PubMed ID: 7599323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunocytochemical detection of normal and abnormal megakaryocytes using monoclonal antibody to glycoprotein IIb-IIIa (TP80): the quantitative assay in normal and in leukaemic patients.
    Sato T; Shichishima T; Kimura H; Uchida T; Kariyone S; Ohto H; Maeda H
    Scand J Haematol; 1986 May; 36(5):415-23. PubMed ID: 2943015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anagrelide does not exert a myelodysplastic effect on megakaryopoiesis: a comparative immunohistochemical and morphometric study with hydroxyurea.
    Thiele J; Kvasnicka HM; Ollig S; Schmitt-Gräff A
    Histol Histopathol; 2005 Oct; 20(4):1071-6. PubMed ID: 16136489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of the tyrosine kinase inhibitor imatinib mesylate (STI571) on bone marrow features in patients with chronic myelogenous leukemia.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Kriener S; Engels K; Staib P; Griesshammer M; Waller CF; Ottmann OG; Hansmann ML
    Histol Histopathol; 2004 Oct; 19(4):1277-88. PubMed ID: 15375771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic significance of detecting pseudo-Pelger-Huët anomalies and micro-megakaryocytes in myelodysplastic syndrome.
    Kuriyama K; Tomonaga M; Matsuo T; Ginnai I; Ichimaru M
    Br J Haematol; 1986 Aug; 63(4):665-9. PubMed ID: 3460627
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Megakaryocytopoiesis and apoptosis in patients with myelodysplastic syndromes.
    Li X; Pu Q
    Leuk Lymphoma; 2005 Mar; 46(3):387-91. PubMed ID: 15621828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Study on pathophysiology of the myelodysplastic syndromes (MDS)--pattern of dysmegakaryopoiesis related to leukemic transformation].
    Tomonaga M; Jinnai I; Kuriyama K; Nonaka H; Amenomori T; Matsuo T; Yoshida Y; Sasagawa I; Sadamori N; Ichimaru M
    Rinsho Ketsueki; 1989 Oct; 30(10):1788-99. PubMed ID: 2593245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
    Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
    Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Megakaryocyte markers in myeloproliferative disorders.
    Iványi JL; Kiss A; Telek B; Tornai I
    Acta Histochem; 1993 Sep; 95(1):79-88. PubMed ID: 7506475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histochemical detection of platelet esterase activity in the bone marrow postmortem: can megakaryocytes serve as indicators for time since death?
    Boehm J; Schmidt U; Veeck J; Porsche M; Schaefer HE
    J Clin Pathol; 2013 Aug; 66(8):711-4. PubMed ID: 23533261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Study on bone marrow megakaryocytes in children patients with myelodysplastic syndrome].
    Shi XD; Hu T; Feng YL; Liu R; Li JH; Wang TY; Chen J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Feb; 12(1):74-8. PubMed ID: 14989774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical significance of micromegakaryocytes in de novo AML].
    Kobayashi S; Seki K; Katayama N; Akiba C; Yamamoto T; Sakai K; Yamaguchi M; Maruta A; Noguchi T; Ogawa K
    Rinsho Ketsueki; 1993 Mar; 34(3):313-20. PubMed ID: 8479083
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A case of atypical chronic myeloid leukemia regarded as MDS with myeloproliferative features.
    Tohda S; Koyama N; Tanaka M; Kida Y; Murakami N; Nara N
    Acta Haematol; 1998; 100(4):191-4. PubMed ID: 9973641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases.
    Aye le L; Loghavi S; Young KH; Siddiqi I; Yin CC; Routbort MJ; Liang M; Eilerman K; Medeiros LJ; Brynes RK; Bueso-Ramos C
    Ann Diagn Pathol; 2016 Apr; 21():53-8. PubMed ID: 27040932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dynamics of CD34+ progenitor cells following allogeneic bone marrow transplantation in Ph1+CML--an immunohistochemical study on 113 patients with sequential trephine biopsies.
    Thiele J; Kvasnicka HM; Beelen DW; Cicek G; Leder LD; Schaefer UW
    J Hematother Stem Cell Res; 2002 Jun; 11(3):565-74. PubMed ID: 12183841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of utility of immunohistochemistry markers as a tool for objective diagnosis of low-grade myelodysplastic syndrome in routine reporting: Prospective observational study.
    Juneja R; Pati H; Dange P; Gupta G; Mahapatra M; Tyagi S; Saxena R
    Indian J Pathol Microbiol; 2022; 65(4):879-885. PubMed ID: 36308198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapy-related changes of CD34+ progenitor cells in chronic myeloid leukemia: a morphometric study on sequential trephine biopsies.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Goekce D; Diehl V; Zankovich R; Schaefer HE
    J Hematother Stem Cell Res; 2001 Dec; 10(6):827-36. PubMed ID: 11798509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Double Ph-positive megakaryoblastic transformation of chronic myeloid leukemia.
    Hirose Y; Masaki Y; Kawabata H; Ogawa N; Wano Y; Sugai S
    Eur J Haematol; 2002 Aug; 69(2):122-5. PubMed ID: 12366719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.